Dr Martens' annual profit surges 61% - Finance news and analysis from Global Banking & Finance Review
Finance

Dr Martens' annual profit surges 61%

Published by Global Banking & Finance Review

Posted on May 19, 2026

2 min read

· Last updated: May 19, 2026

Add as preferred source on Google

Dr Martens' turnaround gathers pace as annual profit jumps 61%

Annual Performance and Strategic Initiatives

Profit Growth and Market Reaction

May 19 (Reuters) - Dr Martens reported a 61% jump in annual earnings on Tuesday and forecast "strong profit" growth this fiscal year as the British bootmaker's strategy of cutting discounts and improving margins appeared to be paying off.

Shares in Dr Martens, known for its lace-up chunky boots, rose more than 9% in early trade, after annual profit rebounded from a 65% decline in the previous year.

CEO Strategy and Operational Changes

That marked progress in CEO Ije Nwokorie's strategy of pulling back on discounting prices and offering promotions across its consumer and wholesale channels.

Cost-Cutting and Inventory Management

The company has also cut inventory and debt as part of a turnaround and cost-cutting drive, after high costs and weak U.S. wholesale demand dented sales and profits. The pressure worsened last year as U.S. tariffs forced the company to absorb additional costs.

Financial Results Overview

Annual adjusted pre-tax profit surged 61.3% to 55 million pounds ($73.78 million) for the year ended March 29, beating analysts' estimates of 51 million pounds, although revenue fell 2.9% to 764.9 million pounds.

Dr Martens' shares have gained more than 20% in the past 12 months on signs its results would improve.

Product Performance and Revenue Breakdown

The bootmaker - which also sells sandals, bags and accessories - said shoes were the standout performer in the year, with revenue rising 19% across models including the 1461 Shoe, Adrian Tassel Loafer and Mary Jane, now accounting for 31% of group revenue compared to 26% a year earlier.

Analyst Insights and Market Outlook

"Beyond the current year, we see ongoing profit recovery and growth potential," Berenberg analysts said in a note.

Direct-to-Consumer Strategy in the U.S.

Dr Martens also said full-price direct-to-consumer revenue in its largest market, the United States, rose 14%, as the company reduced its reliance on discounted sales to wholesale partners.

($1 = 0.7454 pounds)

(Reporting by Yamini Kalia in Bengaluru; Editing by Mrigank Dhaniwala and Susan Fenton)

Key Takeaways

  • Adjusted pre‑tax profit jumped 61.3% year‑on‑year as reduced discounting boosted full‑price sales.
  • The pivot aligns with CEO Ije Nwokorie’s consumer‑first strategy, including expanded product lines and disciplined promotions, supporting margin recovery.
  • This performance marks a sharp rebound from FY25’s steep profit fall and positions Dr Martens to deliver further improvement in FY26, despite FX and tariff headwinds.

Frequently Asked Questions

What was Dr Martens' increase in annual profit?
Dr Martens reported a 61.3% jump in full-year adjusted pre-tax profit.
What contributed to the profit surge for Dr Martens?
The profit surge was driven by the company's pivot to reduced discounting.
Who reported on Dr Martens' financial results?
The results were reported by Yamini Kalia in Bengaluru and edited by Mrigank Dhaniwala.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category